The glycosylation of human serum IgD and IgE and the accessibility of identified oligomannose structures for interaction with mannan-binding lectin

被引:85
作者
Arnold, JN [1 ]
Radcliffe, CM
Wormald, MR
Royle, L
Harvey, DJ
Crispin, M
Dwek, RA
Sim, RB
Rudd, PM
机构
[1] Univ Oxford, Dept Biochem, MRC, Immunochem Unit, Oxford OX1 3QU, England
[2] Univ Oxford, Oxford Glycobiol Inst, Dept Biochem, Oxford OX1 3QU, England
关键词
D O I
10.4049/jimmunol.173.11.6831
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Analysis of the glycosylation of human serum IgD and IgE indicated that oligomannose structures are present on both Igs. The relative proportion of the oligomannose glycans is consistent with the occupation of one N-linked site on each heavy chain. We evaluated the accessibility of the oligomannose glycans on serum IgD and IgE to mannan-binding lectin (MBL). MBL is a member of the collectin family of proteins, which binds to oligomannose sugars. It has already been established that MBL binds to other members of the Ig family, such as agalactosylated glycoforms of IgG and polymeric IgA. Despite the presence of potential ligands; MBL does not bind to immobilized IgD and IgE. Molecular modeling of glycosylated human IgD Fc suggests that the oligomannose glycans located at Asn(354) are inaccessible because the complex glycans at Asn(445) block access to the site. On IgE, the additional C(H)2 hinge domain blocks access to the oligomannose glycans at Asn(394) on one H chain by adopting an asymmetrically bent conformation. IgE contains 8.3% Man(5)GlcNAc(2) glycans, which are the trimmed products of the Glc(3)Man(9)GlcNAc(2) oligomannose precursor. The presence of these structures suggests that the C(H)2 domain flips between two bent quaternary conformations so that the oligomannose glycans on each chain become accessible for limited trimming to Man(5)GlcNAc(2) during glycan biosynthesis. This is the first study of the glycosylation of human serum IgD and IgE from nonmyeloma proteins.
引用
收藏
页码:6831 / 6840
页数:10
相关论文
共 57 条
  • [1] ASHFORD DA, 1993, J BIOL CHEM, V268, P3260
  • [2] BAENZIGER J, 1974, J BIOL CHEM, V249, P1889
  • [3] The Protein Data Bank
    Berman, HM
    Westbrook, J
    Feng, Z
    Gilliland, G
    Bhat, TN
    Weissig, H
    Shindyalov, IN
    Bourne, PE
    [J]. NUCLEIC ACIDS RESEARCH, 2000, 28 (01) : 235 - 242
  • [4] NONSELECTIVE AND EFFICIENT FLUORESCENT LABELING OF GLYCANS USING 2-AMINO BENZAMIDE AND ANTHRANILIC ACID
    BIGGE, JC
    PATEL, TP
    BRUCE, JA
    GOULDING, PN
    CHARLES, SM
    PAREKH, RB
    [J]. ANALYTICAL BIOCHEMISTRY, 1995, 230 (02) : 229 - 238
  • [5] Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis
    Butler, M
    Quelhas, D
    Critchley, AJ
    Carchon, H
    Hebestreit, HF
    Hibbert, RG
    Vilarinho, L
    Teles, E
    Matthijs, G
    Schollen, E
    Argibay, P
    Harvey, DJ
    Dwek, RA
    Jaeken, J
    Rudd, PM
    [J]. GLYCOBIOLOGY, 2003, 13 (09) : 601 - 622
  • [6] NEOGLYCOLIPIDS AS PROBES OF OLIGOSACCHARIDE RECOGNITION BY RECOMBINANT AND NATURAL MANNOSE-BINDING PROTEINS OF THE RAT AND MAN
    CHILDS, RA
    DRICKAMER, K
    KAWASAKI, T
    THIEL, S
    MIZUOCHI, T
    FEIZI, T
    [J]. BIOCHEMICAL JOURNAL, 1989, 262 (01) : 131 - 138
  • [7] CRISPIN MDM, FEBS LETT, V566, P270
  • [8] MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway
    Dahl, MR
    Thiel, S
    Matsushita, M
    Fujita, T
    Willis, AC
    Christensen, T
    Vorup-Jensen, T
    Jensenius, JC
    [J]. IMMUNITY, 2001, 15 (01) : 127 - 135
  • [10] Dong X, 1999, J IMMUNOL, V163, P5427